Paper39458657
Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine.
Serrano DR and 14 others. Pharmaceutics, 2024. Cited by 233 papers, by iCite.
Cite this record
ConductScience Library. Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine. Papers, record 39458657. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39458657
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Innovation in Pharmacology, Nanotechnology, and personalized medicine by 3D printing | Universidad Complutense de Madrid | PubMed | ||
| 05-12ACT-23 | Instituto de las Mujeres and Ministerio de Igualdad | PubMed |
Source PubMed
References159
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36334857 | Perspective on a chemistry classification system for AI-assisted formulation development. | J Control Release | 2022 | https://conductscience.org/library/papers/36334857 | PubMed |
| 2 | 38526539 | Personalized AI-Driven Real-Time Models to Predict Stress-Induced Blood Pressure Spikes Using Wearable Devices: Proposal for a Prospective Cohort Study. | JMIR Res Protoc | 2024 | https://conductscience.org/library/papers/38526539 | PubMed |
| 3 | 38543226 | Advancing Precision Medicine: A Review of Innovative In Silico Approaches for Drug Development, Clinical Pharmacology and Personalized Healthcare. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/38543226 | PubMed |
| 4 | 30397993 | Legal, regulatory, and ethical frameworks for development of standards in artificial intelligence (AI) and autonomous robotic surgery. | Int J Med Robot | 2019 | https://conductscience.org/library/papers/30397993 | PubMed |
| 5 | 38929819 | Revolutionizing Sleep Health: The Emergence and Impact of Personalized Sleep Medicine. | J Pers Med | 2024 | https://conductscience.org/library/papers/38929819 | PubMed |
| 6 | 34393317 | Machine Learning in Drug Discovery: A Review. | Artif Intell Rev | 2022 | https://conductscience.org/library/papers/34393317 | PubMed |
| 7 | 31554996 | An AI boost for clinical trials. | Nature | 2019 | https://conductscience.org/library/papers/31554996 | PubMed |
| 8 | 37555841 | Application of Machine Learning Algorithms to Metadynamics for the Elucidation of the Binding Modes and Free Energy Landscape of Drug/Target Interactions: a Case Study. | Chemistry | 2023 | https://conductscience.org/library/papers/37555841 | PubMed |
| 9 | 37851286 | Towards Responsible AI in Patient Education: Ethical, Linguistic, and Regulatory Considerations. | Obes Surg | 2023 | https://conductscience.org/library/papers/37851286 | PubMed |
| 10 | 31286573 | Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine. | Adv Mater | 2020 | https://conductscience.org/library/papers/31286573 | PubMed |
| 11 | 34013350 | Utilizing graph machine learning within drug discovery and development. | Brief Bioinform | 2021 | https://conductscience.org/library/papers/34013350 | PubMed |
| 12 | 34592448 | A decade of machine learning-based predictive models for human pharmacokinetics: Advances and challenges. | Drug Discov Today | 2022 | https://conductscience.org/library/papers/34592448 | PubMed |
| 13 | 38920405 | DrugFlow: An AI-Driven One-Stop Platform for Innovative Drug Discovery. | J Chem Inf Model | 2024 | https://conductscience.org/library/papers/38920405 | PubMed |
| 14 | 39070092 | The Introduction of AI Into Decentralized Clinical Trials: Preparing for a Paradigm Shift. | JACC Adv | 2024 | https://conductscience.org/library/papers/39070092 | PubMed |
| 15 | 37783543 | A holistic AI-based approach for pharmacovigilance optimization from patients behavior on social media. | Artif Intell Med | 2023 | https://conductscience.org/library/papers/37783543 | PubMed |
| 16 | 33096023 | Predicting Drug Response and Synergy Using a Deep Learning Model of Human Cancer Cells. | Cancer Cell | 2020 | https://conductscience.org/library/papers/33096023 | PubMed |
| 17 | 36748027 | Recent development of machine learning models for the prediction of drug-drug interactions. | Korean J Chem Eng | 2023 | https://conductscience.org/library/papers/36748027 | PubMed |
| 18 | 33099022 | Artificial intelligence in drug discovery and development. | Drug Discov Today | 2021 | https://conductscience.org/library/papers/33099022 | PubMed |
| 19 | 32008227 | Improving Clinical Trial Participant Prescreening With Artificial Intelligence (AI): A Comparison of the Results of AI-Assisted vs Standard Methods in 3 Oncology Trials. | Ther Innov Regul Sci | 2020 | https://conductscience.org/library/papers/32008227 | PubMed |
| 20 | 38440073 | AI enhances drug discovery and development. | Natl Sci Rev | 2024 | https://conductscience.org/library/papers/38440073 | PubMed |
Cited by170
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 233 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42960167 | Knowledge, attitudes, and practices toward artificial intelligence in pharmacy education and practice among pharmacy students and faculty in Bangladesh: a cross-sectional study. | Dialogues Health | 2026 | https://conductscience.org/library/papers/42960167 | PubMed |
| 42950308 | Gen Z perceptions of AI-supported prescription fulfillment in community pharmacy. | Can Pharm J (Ott) | 2026 | https://conductscience.org/library/papers/42950308 | PubMed |
| 42898694 | Redefining drug discovery: AI-driven strategies for efficient cancer therapeutics. | Front Oncol | 2026 | https://conductscience.org/library/papers/42898694 | PubMed |
| 42893259 | Endothelium-targeted and untargeted nanoparticle therapies in thromboinflammatory vascular diseases. | Blood Vessel Thromb Hemost | 2026 | https://conductscience.org/library/papers/42893259 | PubMed |
| 42871779 | Bioinspired Natural Product Nanoplatforms for Precision Cancer Theranostics from Nature to Nanomedicine. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42871779 | PubMed |
| 42797490 | Confidence-Gated Triage: Coupling Drug-Target Affinity and ADME-T Predictions to Prioritise Compounds for Docking. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42797490 | PubMed |
| 42745651 | Uncovering the Potential of 3D Spheroids for Modeling the Cellular Crosstalk Within the Tumor Microenvironment in HNSCC. | Biotechnol J | 2026 | https://conductscience.org/library/papers/42745651 | PubMed |
| 42701419 | From promise to practice: digital health through the lens of neonatal care. | Lancet Reg Health Am | 2026 | https://conductscience.org/library/papers/42701419 | PubMed |
| 42672009 | Computational identification and evaluation of Adenium obesum phytochemicals as potential EGFR inhibitors for targeted therapy against non-small-cell lung cancer. | PLoS One | 2026 | https://conductscience.org/library/papers/42672009 | PubMed |
| 42634960 | Driving Drugs Deeper: Force-Driven Microneedle Systems for Active Therapy and Their Road Towards Clinical Implementation. | Small | 2026 | https://conductscience.org/library/papers/42634960 | PubMed |
| 42631776 | Emerging diagnostic biomarkers and therapeutic targets in Alzheimer's disease. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/42631776 | PubMed |
| 42619255 | Mitochondria-Targeted Nanotherapies in Aging Neurodegenerative Disorders: Emerging Prospects and Clinical Potential. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/42619255 | PubMed |
| 42613493 | Nanotechnology-based immunotherapy: integrating Artificial Intelligence (AI) with current strategies in combating brain cancer disease. | J Egypt Natl Canc Inst | 2026 | https://conductscience.org/library/papers/42613493 | PubMed |
| 42611136 | A survey of transformer and LLM-based architectures, workflows, and systems in drug discovery. | J Comput Aided Mol Des | 2026 | https://conductscience.org/library/papers/42611136 | PubMed |
| 42569261 | In silico drug discovery pipelines targeting antibiotic resistance: from genomes to leads. | Front Bioinform | 2026 | https://conductscience.org/library/papers/42569261 | PubMed |
| 42534998 | Precision antimicrobials: the next paradigm shift after broad-spectrum therapy. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42534998 | PubMed |
| 42515776 | Pulmonary Drug Delivery in the Era of Nanomedicine: From Biological Barriers to Artificial Intelligence-Driven Optimization. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42515776 | PubMed |
| 42514544 | Integrated Phytochemical and Pharmacological Insights into Premna serratifolia for Drug Discovery: A Narrative Review. | Plants (Basel) | 2026 | https://conductscience.org/library/papers/42514544 | PubMed |
| 42506706 | Animal Venoms Targeting Cellular Mechanisms: Advances and Implications for Drug Discovery and Disease Therapy. | Toxins (Basel) | 2026 | https://conductscience.org/library/papers/42506706 | PubMed |
| 42493737 | Advancing Antiviral Design: Integrating Natural Products, Computation and Targeted Delivery. | Chem Biol Drug Des | 2026 | https://conductscience.org/library/papers/42493737 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39458657
GET https://conductscience.org/api/papers/v1/39458657/references?page=2